News
AbbVie climbs post-Allergan M&A peak with Apogee buy
AbbVie has announced its biggest acquisition since the $63 billion merger with Allergan, buying Apogee and its 'mega-blockbuster' immunology pipeline.
News
Boehringer advances duo for aggressive cancers into phase 3
Boehringer Ingelheim steps up its push into oncology with phase 3 trials for pathfinder product Hernexeos and obrixtamig in hard-to-treat cancers.
News
Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance
Insilico Medicine has teamed up with SK Biopharmaceuticals on a wide-ranging, $2.5bn partnership to use AI to find neuroimmune drug candidates.
News
Sanofi names ex-Roche exec Fontoura as R&D chief
Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houmab Ashrafian as Sanofi's R&D head on 1st September.
News
Which biotechs have raised new VC financing this week?
Our latest roundup of financings in the biotech sector includes solid eight-figure rounds for Triveni, Cellares, HMNC, Vedana, and Neion Bio.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
